Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters.

Publication date: Jun 26, 2025

We investigate the long-term impact of repeated COVID-19 vaccinations on adaptive immunity through a 3-year study of 78 individuals without reported symptomatic infections. We observe distinct dynamics in spike-specific responses across multiple vaccine doses. While antibody levels increase and stabilize with each booster, T cell responses quickly plateau and remain stable. Notably, approximately 30% of participants show evidence suggestive of asymptomatic infections. Single-cell RNA sequencing reveals a diverse and stable landscape of spike-specific T cell phenotypes without signs of exhaustion or functional impairment. Individuals with evidence of asymptomatic infection display increased frequencies of Th17-like CD4 T cells and GZMKhi/IFNR CD8 T cell subsets. In this group, repeated vaccinations correlate with an increase in regulatory T cells, potentially indicating a balanced immune response that may mitigate immunopathology. By regularly stimulating T cell memory, boosters contribute to a stable and enhanced immune response, which may provide better protection against symptomatic infections.

Concepts Keywords
Antibody antibody responses
Cd4 asymptomatic infection
Quickly booster vaccination
Th17 COVID-19
Vaccinations CP: Immunology
exhaustion
mRNA vaccines
SARS-CoV-2
scRNA-seq
T cell responses

Semantics

Type Source Name
disease IDO cell
disease MESH COVID-19
disease MESH infections
disease MESH asymptomatic infections
disease IDO immune response
drug DRUGBANK Tropicamide

(Visited 1 times, 1 visits today)